News

MiNK Therapeutics surged 730% on breakthrough testicular cancer data with agenT-797. Click here to read my analysis on INKT ...
New report adds to growing evidence of iNKT cell therapy’s potential in solid tumorsNEW YORK, July 11, 2025 (GLOBE NEWSWIRE) ...
Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the ...
LONDON – Oncogene Cancer Research is proud to announce a £10,425 donation to The Institute of Cancer Research, London (ICR), raised through the efforts of three dedicated runners who took part in this ...
While the classification was made over a decade ago, viral posts on social media have claimed that the birth control pill has ...
The identification of SLC35F2, an oncogene, as the transporter of both q and Q advances our understanding of how intracellular levels of queuine and queuosine are regulated and how their deficiency ...